SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-032457
Filing Date
2024-04-12
Accepted
2024-04-12 13:39:00
Documents
3
Period of Report
2024-04-12

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0203814-6k_akandacorp.htm 6-K 12166
2 PRESS RELEASE ISSUED BY AKANDA CORP. TO ANNOUNCE THAT AKANDA LOOKS TO COMMERCIAL ea020381401ex99-1_akandacorp.htm EX-99.1 12160
3 PRESS RELEASE ISSUED BY AKANDA CORP. TO ANNOUNCE PLANS TO ENTER BLOCKCHAIN AND A ea020381401ex99-2_akandacorp.htm EX-99.2 11344
  Complete submission text file 0001213900-24-032457.txt   36744
Mailing Address 77 KING STREET WEST, SUITE 400 C/O DENTONS CANADA LLP TORONTO A6 M5K 0A1
Business Address 1A, 1B LEAROYD ROAD NEW ROMNEY X0 TN28 8XU 442034889514
AKANDA CORP. (Filer) CIK: 0001888014 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41324 | Film No.: 24840829
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)